EMAS
 

Position Statements

EMAS position statement:


Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis.
Maturitas. July 2017;101:23-30
Read more


Interventions to reduce the risk of ovarian and fallopian tube cancer.
Maturitas. June 2017;100:86-91

Read more


Osteoporosis management in patients with breast cancer. Maturitas. 2017 Jan;95:65-71
Read more

A model of care for healthy menopause and ageing. Maturitas.2016.06.018
Read more

Maintening postreproductive health: A care pathway from the European Menopause and Andropause Society. Maturitas 2016; 89:63-72.
Read more


EMAS recommendations for conditions in the workplace for menopausal women. Maturitas. 2016; 85: 79–81.
Read more


Testosterone replacement therapy in the aging male. Maturitas. 2016;84:94-9.
Read more


Non-hormonal management of menopausal vasomotor symptoms. Maturitas. 2015;81:410-3.
Read more


The ten point guide to the integral management of menopausal health. Maturatis 2015;81:88-92.
Read more


Individualized breast cancer screening versus population- based mammography screening programmes. Maturitas 2014;79:481-486.
Read more


Management of uterine fibroids. Maturitas. 2014 ; 79: 106– 116.
Read more


The management of postmenopausal women with vertebral osteoporotic fracture. Maturitas. 2014 ; 78: 131–137.
Read more


Menopause for medical students. Maturitas. 2014 ; 78: 67– 69.
Read more


Fertility preservation. Maturitas. 2014 ; 77: 85–89.
Read more


Late parenthood. Maturitas. 2013;76: 200–4.
Read more


Diet and health in midlife and beyond. 2013;74: 99–104.
Read more


Vitamin D and postmenopausal health. 2012 Jan.;71: 83–8.
Read more

EMAS

EMAS ADMINISTRATIVE OFFICE · c/o K.I.T. Group GmbH · Association & Conference Management · Kurfürstendamm 71 · D - 10709 Berlin
Tel: +49 (0)30 24603-0 · Fax: +49 (0)30 24603-310 · E-mail: info@emas-online.org · Internet: www.emas-online.org